cilostazol has been researched along with ng-nitroarginine methyl ester in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inada, H; Onaya, T; Shindo, H; Tawata, M | 1 |
| Fukutomi, T; Imaeda, K; Itoh, M; Nakamura, A; Okayama, N; Okouchi, M; Omi, H; Shimizu, M | 1 |
| Ikomi, F; Nakamura, K; Ohhashi, T | 1 |
| Hashimoto, A; Hirose, Y; Miyakoda, G; Mori, T | 1 |
| Aoyama, T; Bai, Y; Iwasa, M; Minatoguchi, S; Murakami, H; Nishigaki, K; Sumi, S; Takemura, G; Uno, B; Ushikoshi, H; Yamada, Y | 1 |
| Hori, A; Komori, K; Morisaki, K; Murohara, T; Shibata, R | 1 |
| Dreier, JP; Hirayama, Y; Hiyoshi, K; Inoue, T; Ishihara, H; Kawano, A; Kawano, R; Kiyohira, M; Maruta, Y; Nomura, S; Oka, F; Okazaki, K; Oku, T; Sadahiro, H; Shinoyama, M; Shirao, S; Suehiro, E; Sugimoto, K; Suzuki, M; Yoneda, H | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
1 trial(s) available for cilostazol and ng-nitroarginine methyl ester
| Article | Year |
|---|---|
Cilostazol decreases duration of spreading depolarization and spreading ischemia after aneurysmal subarachnoid hemorrhage.
Topics: Aged; Animals; Brain Ischemia; Cerebrovascular Circulation; Cilostazol; Cortical Spreading Depression; Disease Models, Animal; Female; Follow-Up Studies; Humans; Intracranial Aneurysm; Male; Middle Aged; Neuroprotective Agents; NG-Nitroarginine Methyl Ester; Potassium Chloride; Rats; Rats, Sprague-Dawley; Retrospective Studies; Subarachnoid Hemorrhage | 2018 |
7 other study(ies) available for cilostazol and ng-nitroarginine methyl ester
| Article | Year |
|---|---|
Cilostazol, a cyclic AMP phosphodiesterase inhibitor, stimulates nitric oxide production and sodium potassium adenosine triphosphatase activity in SH-SY5Y human neuroblastoma cells.
Topics: Cilostazol; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dexamethasone; Humans; Inositol; Isoquinolines; Neuroblastoma; NG-Nitroarginine Methyl Ester; Nitric Oxide; Phosphodiesterase Inhibitors; Sodium-Potassium-Exchanging ATPase; Sorbitol; Sulfonamides; Tetrazoles; Tumor Cells, Cultured | 1999 |
Cilostazol inhibits high glucose-mediated endothelial-neutrophil adhesion by decreasing adhesion molecule expression via NO production.
Topics: Cell Adhesion; Cells, Cultured; Cilostazol; Endothelium, Vascular; Enzyme Inhibitors; Glucose; Humans; In Vitro Techniques; Intercellular Adhesion Molecule-1; Neutrophils; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Ornithine; P-Selectin; Protein Kinase C; Tetradecanoylphorbol Acetate; Tetrazoles | 2004 |
Cilostazol, an inhibitor of type 3 phosphodiesterase, produces endothelium-independent vasodilation in pressurized rabbit cerebral penetrating arterioles.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Arterioles; Aspirin; Cerebrovascular Circulation; Cilostazol; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclooxygenase Inhibitors; Drug Interactions; Endothelium, Vascular; Enzyme Inhibitors; Glyburide; Hypoglycemic Agents; In Vitro Techniques; Male; Milrinone; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroprusside; Phosphodiesterase Inhibitors; Pressure; Prostaglandins; Rabbits; Tetrazoles; Vasodilation; Vasodilator Agents | 2006 |
Activation of endothelial nitric oxide synthase by cilostazol via a cAMP/protein kinase A- and phosphatidylinositol 3-kinase/Akt-dependent mechanism.
Topics: Aorta; Blotting, Western; Cell Division; Cells, Cultured; Chromones; Cilostazol; Cyclic AMP-Dependent Protein Kinases; Endothelium, Vascular; Enzyme Activation; Enzyme Inhibitors; Humans; Morpholines; Neovascularization, Physiologic; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Phosphatidylinositol 3-Kinases; Phosphodiesterase Inhibitors; Phosphorylation; Tetrazoles | 2006 |
Cilostazol protects the heart against ischaemia reperfusion injury in a rabbit model of myocardial infarction: focus on adenosine, nitric oxide and mitochondrial ATP-sensitive potassium channels.
Topics: Adenosine; Animals; Cardiotonic Agents; Cilostazol; Decanoic Acids; Disease Models, Animal; Drug Evaluation, Preclinical; Enzyme Inhibitors; Humans; Hydroxy Acids; Myocardial Infarction; NG-Nitroarginine Methyl Ester; Nitric Oxide; Potassium Channel Blockers; Purinergic P1 Receptor Antagonists; Rabbits; Reperfusion Injury; Superoxides; Tetrazoles; Theophylline | 2011 |
Cilostazol stimulates revascularisation in response to ischaemia via an eNOS-dependent mechanism.
Topics: Angiogenesis Inducing Agents; Animals; Blotting, Western; Capillaries; Cilostazol; Disease Models, Animal; Hindlimb; Immunohistochemistry; Ischemia; Laser-Doppler Flowmetry; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Skeletal; Neovascularization, Physiologic; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Phosphodiesterase 3 Inhibitors; Platelet Endothelial Cell Adhesion Molecule-1; Tetrazoles; Time Factors | 2012 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |